[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341323-105":59,"doc-detail-341323-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","global-burden-of-disease-study-analysis-of-thyroid-cancer-burden-across-204-countries-and-territories-from-1990-to-2019","Global burden of disease study analysis of thyroid cancer burden across 204 countries and territories from 1990 to 2019","","Global burden of disease analysis evaluates thyroid cancer burden over 30 years across 204 countries and territories. Using GBD 2019 data, the study estimates prevalence, deaths, DALYs, YLL, YLD and corresponding age-standardized rates at global, regional and national levels. Trends from 1990–2019 are quantified with EAPC for ASPR, ASDR and ASDR. Results project 18.3 million cases in 2019, show increasing age-standardized prevalence and decreasing mortality and DALYs, and link burden with sex and SDI.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-burden-of-disease-study-analysis-of-thyroid-cancer-burden-across-204-countries-and-territories-from-1990-to-2019/341323/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-burden-of-disease-study-analysis-of-thyroid-cancer-burden-across-204-countries-and-territories-from-1990-to-2019/341323.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What data sources and period were used to assess thyroid cancer burden?","Question",{"text":113,"@type":114},"The analysis uses the Global Burden of Disease (GBD) 2019 database, covering thyroid cancer outcomes from 1990 to 2019 across 204 countries and territories.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which burden metrics are extracted in this study?",{"text":118,"@type":114},"The study extracts prevalence, deaths, DALYs, YLL, YLD, and the corresponding age-standardized rates at global, regional, and national levels.",{"name":120,"@type":111,"acceptedAnswer":121},"How are temporal trends in burden quantified from 1990 to 2019?",{"text":122,"@type":114},"Temporal trends are summarized using Estimated Annual Percentage Change (EAPC) for ASPR and ASDR (including ASDR for deaths and DALYs-related measures as described).",{"name":124,"@type":111,"acceptedAnswer":125},"What major patterns are reported in the results?",{"text":126,"@type":114},"Across 1990–2019, age-standardized prevalence rises globally while deaths and DALYs decrease; females consistently show higher cases, deaths, and DALYs than males, and higher SDI relates to higher age-standardized prevalence rates.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},341323,1790098749,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","TYPE Original Research PUBLISHED 28 May 2024  \nDOI 10.3389/fonc.2024.1412243  \nOPEN ACCESS  \nEDITED BY  \nJan Baptist Vermorken, University of Antwerp, Belgium  \nREVIEWED BY  \nAkira Sugawara, Tohoku University, Japan Barbara Maria Jarzab,  \nMaria Skłodowska-Curie National Research Institute of Oncology, Poland  \n*CORRESPONDENCE Jinzhu Jia  \n[jzjia@math.pku.edu.cn](jzjia@math.pku.edu.cn)[ ](jzjia@math.pku.edu.cn)Yanyan Shi  \n [shiyanyan@bjmu.edu.cn](shiyanyan@bjmu.edu.cn)  \nRECEIVED 04 April 2024  \nACCEPTED 13 May 2024  \nPUBLISHED 28 May 2024  \nCITATION  \nDou Z, Shi Y and Jia J (2024) Global burden of disease study analysis of thyroid cancer burden across 204 countries and territories from 1990 to 2019 .  \nFront. Oncol. 14:1412243 .  \ndoi: 10.3389/fonc.2024.1412243  \nCOPYRIGHT  \n© 2024 Dou, Shi and Jia. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nGlobal burden of disease study analysis of thyroid cancer burden across 204 countries and territories from 1990 to 2019  \nZhili Dou 1, Yanyan Shi 2* and Jinzhu Jia 1,3*  \n1 Department of Biostatistics, School of Public Health, Peking University, Beijing, China, 2 Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China, 3Center for Statistical Science, Peking University, Beijing, China  \nBackground: The purpose of this study is to assess the burden of thyroid cancer over the course of 30 years in 204 countries and territories.  \nMethods: Data from the Global Burden of Disease (GBD) 2019 database was analyzed to extract information on prevalence, deaths, DALYs(disability-adjusted life-years), YLL(years of life los), YLD(years lived with disability), and their corresponding age-standardized rates at global, regional, and national levels. The primary focus of the study was to examine trends in thyroid cancer from 1990 to 2019, speciﬁcally looking at the Estimated Annual Percentage Change (EAPC) for ASPR, ASDR, and ASDR. Additionally, the study investigated the relationship between cancer burden and the Socio-Demographic Index (SDI) .  \nResults: Globally, there will be approximately 18 .3 million thyroid cancer (TC) cases in 2019; China and the USA are projected to be the most signiﬁcant with 310,327 and 220,711 cases (16.17 and 14.82 cases per 100,000 people, respectively).Over the period from 1990 to 2019, age-standardized prevalence rates exhibited a global rise, whereas deaths and DALYs saw a decrease (EAPC:1 . 63, –0.15- –0. 14, respectively) . Signiﬁcantly, the age-standardized prevalence rate increased in 21 GBD regions, affecting 195 out of 204 countries or territories. Over the studied period, thyroid cancer cases, deaths, and DALYs were consistently higher among females than males. Furthermore, a higher Socio-demographic Index was associated with increased agestandardized prevalence rates.  \nKEYWORDS  \nburden of disease, disability-adjusted life-years, prevalence, incidence, deaths  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nThyroid cancer(TC) stands as the most prevalent endocrine cancer on a global scale (1) . Over recent decades, numerous research have noted a consistent upward trend (2) in thyroid cancer incidence across various countries and regions, including Canada (3), the US (4), Australia (5), Asia (6–8), South America (9), and Europe (10–13).While several regional studies have provided insights into thyroid cancer’s incidence and mortality rates (14, 15), research examining its correlation with factors like country, gender, age, and sociodemographic index (SDI) remains limited. A comprehensive analysis ","cbCaikXca7SHC0e3","https://ap.wps.com/l/cbCaikXca7SHC0e3","pdf",2510428,"English","# Introduction\n# Methods\n## Collection of data\n# Results","[{\"question\":\"What data sources and period were used to assess thyroid cancer burden?\",\"answer\":\"The analysis uses the Global Burden of Disease (GBD) 2019 database, covering thyroid cancer outcomes from 1990 to 2019 across 204 countries and territories.\"},{\"question\":\"Which burden metrics are extracted in this study?\",\"answer\":\"The study extracts prevalence, deaths, DALYs, YLL, YLD, and the corresponding age-standardized rates at global, regional, and national levels.\"},{\"question\":\"How are temporal trends in burden quantified from 1990 to 2019?\",\"answer\":\"Temporal trends are summarized using Estimated Annual Percentage Change (EAPC) for ASPR and ASDR (including ASDR for deaths and DALYs-related measures as described).\"},{\"question\":\"What major patterns are reported in the results?\",\"answer\":\"Across 1990–2019, age-standardized prevalence rises globally while deaths and DALYs decrease; females consistently show higher cases, deaths, and DALYs than males, and higher SDI relates to higher age-standardized prevalence rates.\"}]","Global burden of disease study analysis of thyroid cancer burden across 204 countries and territories from 1990 to 2019 | PDF",1790041537,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d26278449950d140151c6af4718e2b9.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c59ee84212dbccd5f5ec18d0f874ad0.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/963687a0a4e006204d5df89c2b5c53e9.webp",981,1386,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be2ca0145729f476788f1f5071a285f7.webp",980,692]